JP2020529410A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529410A5 JP2020529410A5 JP2020505208A JP2020505208A JP2020529410A5 JP 2020529410 A5 JP2020529410 A5 JP 2020529410A5 JP 2020505208 A JP2020505208 A JP 2020505208A JP 2020505208 A JP2020505208 A JP 2020505208A JP 2020529410 A5 JP2020529410 A5 JP 2020529410A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023075458A JP2023106433A (ja) | 2017-07-31 | 2023-05-01 | Ｎｋｇ２ｄ、ｃｄ１６及びｆｌｔ３と結合するタンパク質 |
| JP2025092507A JP2025131681A (ja) | 2017-07-31 | 2025-06-03 | Ｎｋｇ２ｄ、ｃｄ１６及びｆｌｔ３と結合するタンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762539421P | 2017-07-31 | 2017-07-31 | |
| US62/539,421 | 2017-07-31 | ||
| PCT/US2018/044610 WO2019028027A1 (en) | 2017-07-31 | 2018-07-31 | PROTEINS BINDING TO NKG2D, CD16 AND FLT3 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023075458A Division JP2023106433A (ja) | 2017-07-31 | 2023-05-01 | Ｎｋｇ２ｄ、ｃｄ１６及びｆｌｔ３と結合するタンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020529410A JP2020529410A (ja) | 2020-10-08 |
| JP2020529410A5 true JP2020529410A5 (https=) | 2021-09-24 |
Family
ID=65233032
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505208A Pending JP2020529410A (ja) | 2017-07-31 | 2018-07-31 | Ｎｋｇ２ｄ、ｃｄ１６及びｆｌｔ３と結合するタンパク質 |
| JP2023075458A Pending JP2023106433A (ja) | 2017-07-31 | 2023-05-01 | Ｎｋｇ２ｄ、ｃｄ１６及びｆｌｔ３と結合するタンパク質 |
| JP2025092507A Pending JP2025131681A (ja) | 2017-07-31 | 2025-06-03 | Ｎｋｇ２ｄ、ｃｄ１６及びｆｌｔ３と結合するタンパク質 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023075458A Pending JP2023106433A (ja) | 2017-07-31 | 2023-05-01 | Ｎｋｇ２ｄ、ｃｄ１６及びｆｌｔ３と結合するタンパク質 |
| JP2025092507A Pending JP2025131681A (ja) | 2017-07-31 | 2025-06-03 | Ｎｋｇ２ｄ、ｃｄ１６及びｆｌｔ３と結合するタンパク質 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20200165344A1 (https=) |
| EP (1) | EP3661554A4 (https=) |
| JP (3) | JP2020529410A (https=) |
| KR (2) | KR20200033302A (https=) |
| CN (1) | CN111132698A (https=) |
| AU (2) | AU2018309712A1 (https=) |
| BR (1) | BR112020001972A2 (https=) |
| CA (1) | CA3070986A1 (https=) |
| CO (1) | CO2020001981A2 (https=) |
| EA (1) | EA202090387A1 (https=) |
| IL (1) | IL272374A (https=) |
| MA (1) | MA49769A (https=) |
| MX (1) | MX2020001257A (https=) |
| SG (1) | SG11202000632QA (https=) |
| WO (1) | WO2019028027A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201907299XA (en) | 2017-02-08 | 2019-09-27 | Dragonfly Therapeutics Inc | Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer |
| IL268755B2 (en) | 2017-02-20 | 2025-12-01 | Dragonfly Therapeutics Inc | Proteins that bind her2, nkg2d, and cd16 |
| EA202091887A1 (ru) | 2018-02-08 | 2020-10-23 | Драгонфлай Терапьютикс, Инк. | Комбинированная терапия рака с применением мультиспецифических связывающих белков, которые активируют естественные клетки-киллеры |
| DK3749346T3 (da) | 2018-02-08 | 2024-09-09 | Dragonfly Therapeutics Inc | Antistof variable domænekombinationer rettet mod nkg2d-receptoren |
| WO2019164930A1 (en) | 2018-02-20 | 2019-08-29 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use |
| MX2020010003A (es) | 2018-03-27 | 2021-01-15 | Xyphos Biosciences Inc | Dominios a1-a2 modificados de ligandos nkg2d no naturales que se unen a receptores nkg2d no naturales. |
| US12378318B2 (en) | 2018-08-08 | 2025-08-05 | Dragonfly Therapeutics, Inc. | Proteins binding NKG2D, CD16 and a tumor-associated antigen |
| EA202091888A1 (ru) | 2018-08-08 | 2020-10-23 | Драгонфлай Терапьютикс, Инк. | Вариабельные домены антител, нацеленные на рецептор nkg2d |
| WO2020033630A1 (en) | 2018-08-08 | 2020-02-13 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins that bind bcma, nkg2d and cd16, and methods of use |
| JP7642542B2 (ja) | 2018-12-18 | 2025-03-10 | ベーリンガー・インゲルハイム・イオ・カナダ・インコーポレイテッド | Ｆｌｔ３アゴニスト抗体及びその使用 |
| MX2022004430A (es) * | 2019-10-15 | 2022-07-19 | Dragonfly Therapeutics Inc | Proteinas que se unen al receptor activador de celulas asesinas naturales grupo 2 miembro d (nkg2d), al cumulo de diferenciacion 16 (cd16) y a la tirosina cinasa 3 similar a fms (flt3). |
| CA3170833A1 (en) * | 2020-02-21 | 2021-08-26 | Harpoon Therapeutics, Inc. | Flt3 binding proteins and methods of use |
| MX2022013944A (es) | 2020-05-06 | 2022-11-30 | Dragonfly Therapeutics Inc | Proteinas que se unen al receptor activador de celulas asesinas naturales grupo 2 miembro d (nkg2d), cumulo de diferenciacion (cd16) y miembro a de la familia de dominios de lectina tipo c 12 (clec12a). |
| JP2024508894A (ja) | 2021-03-03 | 2024-02-28 | ドラゴンフライ セラピューティクス， インコーポレイテッド | Ｎｋｇ２ｄ、ｃｄ１６、及び腫瘍関連抗原に結合する多特異性結合タンパク質を使用して癌を治療する方法 |
| WO2023274183A1 (zh) * | 2021-06-29 | 2023-01-05 | 江苏先声药业有限公司 | Cd16抗体及其应用 |
| WO2026052582A1 (en) | 2024-09-04 | 2026-03-12 | Red Ridge Bio Ag | Biparatopic antibodies that specifically bind fms related receptor tyrosine kinase 3 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101615935B1 (ko) * | 2007-12-14 | 2016-04-28 | 노보 노르디스크 에이/에스 | 인간 ｎｋｇ2ｄ에 대한 항체 및 그것의 용도 |
| AR071891A1 (es) * | 2008-05-30 | 2010-07-21 | Imclone Llc | Anticuerpos humanos anti-flt3 (receptor tirosina cinasa 3 tipo fms humano) |
| UY32808A (es) * | 2009-07-29 | 2011-02-28 | Abbott Lab | Inmunoglobulinas como dominio variable dual y usos de las mismas |
| HRP20160422T1 (hr) * | 2009-12-23 | 2016-05-20 | Synimmune Gmbh | Protutijela protiv flt3 postupci njihove upotrebe |
| UY33492A (es) * | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| LT2794658T (lt) * | 2011-12-19 | 2017-05-10 | Synimmune Gmbh | Bispecifinė antikūno molekulė |
| EP4310191A3 (en) * | 2012-06-14 | 2024-05-15 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule containing modified fc region |
| EP3126384B1 (en) * | 2014-04-01 | 2020-12-02 | Adimab, LLC | Multispecific antibody analogs comprising a common light chain, and methods of their preparation and use |
| WO2016166139A1 (en) * | 2015-04-14 | 2016-10-20 | Eberhard Karls Universität Tübingen | Bispecific fusion proteins for enhancing immune responses of lymphocytes against tumor cells |
-
2018
- 2018-07-31 BR BR112020001972-0A patent/BR112020001972A2/pt not_active Application Discontinuation
- 2018-07-31 MX MX2020001257A patent/MX2020001257A/es unknown
- 2018-07-31 US US16/635,079 patent/US20200165344A1/en not_active Abandoned
- 2018-07-31 EA EA202090387A patent/EA202090387A1/ru unknown
- 2018-07-31 JP JP2020505208A patent/JP2020529410A/ja active Pending
- 2018-07-31 KR KR1020207005238A patent/KR20200033302A/ko not_active Ceased
- 2018-07-31 WO PCT/US2018/044610 patent/WO2019028027A1/en not_active Ceased
- 2018-07-31 CN CN201880062880.1A patent/CN111132698A/zh active Pending
- 2018-07-31 EP EP18840650.8A patent/EP3661554A4/en active Pending
- 2018-07-31 AU AU2018309712A patent/AU2018309712A1/en not_active Abandoned
- 2018-07-31 MA MA049769A patent/MA49769A/fr unknown
- 2018-07-31 CA CA3070986A patent/CA3070986A1/en active Pending
- 2018-07-31 KR KR1020257011280A patent/KR20250051800A/ko active Pending
- 2018-07-31 SG SG11202000632QA patent/SG11202000632QA/en unknown
-
2020
- 2020-01-30 IL IL272374A patent/IL272374A/en unknown
- 2020-02-25 CO CONC2020/0001981A patent/CO2020001981A2/es unknown
-
2023
- 2023-05-01 JP JP2023075458A patent/JP2023106433A/ja active Pending
-
2025
- 2025-06-03 JP JP2025092507A patent/JP2025131681A/ja active Pending
- 2025-06-19 AU AU2025204591A patent/AU2025204591A1/en active Pending